Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine M Vos

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|December 7, 2017
Ecthyma GangrenosumAnna K M Korte, Josephine M Vos
Haematologica|June 30, 2022
IgM monoclonal gammopathies of clinical significance: diagnosis and managementJahanzaib Khwaja, Shirley D'Sa, Monique C Minnema, et al.
The American Journal of Cardiology|January 17, 2016
Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± ChemotherapyJesse M Bijl, Marleen M Roos, Elena M van Leeuwen-Segarceanu, et al.
British Journal of Haematology|February 16, 2017
Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panelShirley D'Sa, Marie José Kersten, Jorge J Castillo, et al.
British Journal of Haematology|July 30, 2016
Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomesJosephine M Vos, Joshua Gustine, Helmut G Rennke, et al.
Haematologica|August 12, 2017
CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinibJosephine M Vos, Nickolas Tsakmaklis, Christopher J Patterson, et al.
Blood|June 16, 2016
Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Guang Yang, et al.
The Lancet. Haematology|October 22, 2020
Consensus treatment recommendations from the tenth International Workshop for Waldenström MacroglobulinaemiaJorge J Castillo, Ranjana H Advani, Andrew R Branagan, et al.
Hemasphere|August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 PandemicDipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Haematologica|November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemiaEric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|December 7, 2017
Ecthyma GangrenosumAnna K M Korte, Josephine M Vos
Haematologica|June 30, 2022
IgM monoclonal gammopathies of clinical significance: diagnosis and managementJahanzaib Khwaja, Shirley D'Sa, Monique C Minnema, et al.
The American Journal of Cardiology|January 17, 2016
Assessment of Valvular Disorders in Survivors of Hodgkin's Lymphoma Treated by Mediastinal Radiotherapy ± ChemotherapyJesse M Bijl, Marleen M Roos, Elena M van Leeuwen-Segarceanu, et al.
British Journal of Haematology|February 16, 2017
Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panelShirley D'Sa, Marie José Kersten, Jorge J Castillo, et al.
British Journal of Haematology|July 30, 2016
Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomesJosephine M Vos, Joshua Gustine, Helmut G Rennke, et al.
Haematologica|August 12, 2017
CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinibJosephine M Vos, Nickolas Tsakmaklis, Christopher J Patterson, et al.
Blood|June 16, 2016
Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Guang Yang, et al.
The Lancet. Haematology|October 22, 2020
Consensus treatment recommendations from the tenth International Workshop for Waldenström MacroglobulinaemiaJorge J Castillo, Ranjana H Advani, Andrew R Branagan, et al.
Hemasphere|August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 PandemicDipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Haematologica|November 12, 2020
A prognostic index predicting survival in transformed Waldenström macroglobulinemiaEric Durot, Lukshe Kanagaratnam, Saurabh Zanwar, et al.
Pageof 2